-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on Clene, Lowers Price Target to $31

Benzinga·09/10/2025 12:21:40
Listen to the news
Benchmark analyst Bruce D. Jackson maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $33 to $31.